kristina [she/her]@hexbear.net to science@hexbear.netEnglish · edit-213 days agoGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.www.cnbc.comexternal-linkmessage-square7fedilinkarrow-up173arrow-down10cross-posted to: [email protected][email protected][email protected][email protected][email protected][email protected][email protected]
arrow-up173arrow-down1external-linkGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.www.cnbc.comkristina [she/her]@hexbear.net to science@hexbear.netEnglish · edit-213 days agomessage-square7fedilinkcross-posted to: [email protected][email protected][email protected][email protected][email protected][email protected][email protected]
minus-squaregit [he/him, comrade/them]@hexbear.netlinkfedilinkEnglisharrow-up5·13 days agoCountries outside of the western pharmaceutical patent treaties will produce generics in due time.
Countries outside of the western pharmaceutical patent treaties will produce generics in due time.